Kezar Life Sciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Results of Operations and Financial Condition, Financial Statements and Exhibits